Shell Asset Management CO Neogenomics Inc Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

A detailed history of Shell Asset Management CO transactions in Neogenomics Inc stock. As of the latest transaction made, Shell Asset Management CO holds 4,355 shares of NEO stock, worth $64,715. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,355

Previous 4,623 5.8%

Holding current value

$64,715

Previous $64,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$13.4 - $17.73 $3,591 - $4,751	-268 Reduced 5.8%	4,355 $64,000
Q1 2024 Jul 31, 2024	SELL	$14.06 - $16.79 $3,993 - $4,768	-284 Reduced 5.79%	4,623 $64,000
Q1 2024 May 14, 2024	SELL	$14.06 - $16.79 $3,824 - $4,566	-272 Reduced 5.25%	4,907 $77,000
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $17,551 - $31,177	-1,504 Reduced 22.5%	5,179 $84,000
Q3 2023 Nov 08, 2023	SELL	$12.15 - $17.85 $1,251 - $1,838	-103 Reduced 1.52%	6,683 $82,000
Q2 2023 Jul 28, 2023	SELL	$14.1 - $19.83 $578 - $813	-41 Reduced 0.6%	6,786 $109,000
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $209 - $447	-23 Reduced 0.34%	6,827 $119,000
Q4 2022 Feb 07, 2023	SELL	$6.45 - $12.07 $3,424 - $6,409	-531 Reduced 7.19%	6,850 $63,000
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $7,451 - $12,238	-948 Reduced 11.38%	7,381 $64,000
Q2 2022 Aug 09, 2022	BUY	$7.06 - $13.97 $769 - $1,522	109 Added 1.33%	8,329 $68,000
Q1 2022 May 04, 2022	SELL	$12.15 - $35.28 $14,944 - $43,394	-1,230 Reduced 13.02%	8,220 $100,000
Q4 2021 Feb 09, 2022	BUY	$30.49 - $48.49 $176,415 - $280,563	5,786 Added 157.91%	9,450 $322,000
Q3 2021 Nov 04, 2021	SELL	$41.66 - $52.52 $7,082 - $8,928	-170 Reduced 4.43%	3,664 $177,000
Q1 2021 May 10, 2021	BUY	$41.56 - $59.88 $159,341 - $229,579	3,834 New	3,834 $185,000

Others Institutions Holding NEO

# of Institutions

292

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.87B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Neogenomics Inc Transaction History